International Patent: TREATMENT OF PREVIOUSLY TREATED SUBJECTS HAVING COLORECTAL CANCER USING AN ANTI-EGFR RECHALLENGE TREATMENT WITH A BISPECIFIC ANTIBODY THAT BINDS EGFR AND CMET

GENEVA, July 2 -- MERUS B.V. filed a patent application (CN2025/142402) for “TREATMENT OF PREVIOUSLY TREATED SUBJECTS HAVING COLORECTAL CANCER USING AN ANTI-EGFR RECHALLENGE TREATMENT WITH A BISPECIFIC ANTIBODY THAT BINDS EGFR AND CMET”. With publication no. WO/2026/130279, here are the other details related to the patent application:

Kind: Initial Publication without ISR [A2]

IPC: none

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....